Bayer Aktiengesellschaft (BAYZF)
OTCMKTS
· Delayed Price · Currency is USD
27.97
+1.18 (4.40%)
May 13, 2025, 4:00 PM EDT
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 13.74B EUR in the quarter ending March 31, 2025, a decrease of -0.20%. This brings the company's revenue in the last twelve months to 46.58B, down -0.92% year-over-year. In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B, down -2.16%.
Revenue (ttm)
46.58B EUR
Revenue Growth
-0.92%
P/S Ratio
0.48
Revenue / Employee
514.19K EUR
Employees
90,587
Market Cap
24.40B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Bayer Aktiengesellschaft News
- 1 day ago - Bayer: U.S. Supreme Court could decide in June whether it will hear glyphosate case - Reuters
- 1 day ago - Bayer shares soar as company records strong cancer drug demand - Euronews
- 1 day ago - Bayer Shares Jump After Results Beat Expectations on Pharma Strength - The Wall Street Journal
- 1 day ago - Bayer posts smaller than expected 7.4% drop in quarterly adjusted profit - Reuters
- 1 day ago - Bayer AG Non-GAAP EPS of €2.49, revenue of €13.74B; updates FY25 outlook - Seeking Alpha
- 1 day ago - Second US state moves to shield Bayer from Roundup claims - Independent Ireland
- 2 days ago - Georgia’s governor is shielding Roundup weed killer’s maker from cancer warning lawsuits - Fortune
- 2 days ago - Bayer to overhaul Crop Science division, cutting hundreds of jobs - Seeking Alpha